| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Technical Officer
1 company
Nicholson Nur is a Chief Technical Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $4.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | APLS Apellis Pharmaceuticals, Inc. | Chief Technical Officer | Sell | 2,618 | $22.19 | $58,086.09 | -3.1% | +91.2% | - | |
| Jan 29, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Technical Officer | Sell | 825 | $29.52 | $24,356.97 | -1.0% | -38.2% | -21.8% | |
| Jan 22, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Technical Officer | Sell | 3,948 | $30.43 | $120,119.87 | -4.5% | -42.8% | -27.6% | |
| Jan 17, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Technical Officer | Sell | 2,145 | $29.96 | $64,260.34 | -4.0% | -39.2% | -33.4% | |
| Jan 13, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Technical Officer | Sell | 2,632 | $28.70 | $75,543.93 | -4.6% | -32.4% | -25.4% | |
| Mar 13, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Technical Officer | Sell | 11,220 | $57.56 | $645,837.62 | -8.8% | -25.5% | -57.5% | |
| Jan 29, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Technical Officer | Sell | 835 | $64.14 | $53,555.40 | -1.2% | -26.8% | -55.2% | |
| Jan 22, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Technical Officer | Sell | 2,593 | $65.00 | $168,534.63 | -3.7% | -27.2% | -54.0% | |
| Jan 16, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Technical Officer | Sell | 1,857 | $66.81 | $124,063.57 | -2.6% | -22.3% | -56.2% | |
| Sep 18, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Technical Officer | Sale+OE | 20,350 | $44.27 | $900,813.17 | -14.8% | +19.1% | -24.4% |